Status:
UNKNOWN
Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9
Lead Sponsor:
German High-Grade Non-Hodgkin's Lymphoma Study Group
Conditions:
Long-term Effects Secondary to Cancer Therapy in Adults
Lymphoma
Eligibility:
All Genders
18-60 years
Brief Summary
RATIONALE: Treatment for diffuse large B-cell non-Hodgkin's lymphoma may cause side effects and secondary cancers later in life. An observational study that evaluates patients after undergoing six cou...
Detailed Description
OBJECTIVES: * Gain information on the long-term efficacy of 6 courses of CHOP (cyclophosphamide, doxorubicin hydrochloride, prednisone, and vincristine)-like chemotherapy with vs without rituximab (p...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Patients recruited for protocol CAN-NCIC-LY9 and evaluated in the first planned final analysis as of June 2005
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
667 Patients enrolled
Trial Details
Trial ID
NCT00400907
Start Date
January 1 2006
Last Update
December 20 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.